Clinical Trial Update: Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating imaging of T-cell activation using [18F]F-AraG in advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• [18F]F-AraG

Snippet

Sponsor: CellSight Technologies, Inc. | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN